UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ OR o SHELL COMPANY PURSUANT T ...

Interims 2020 10 September 2020 The Midatech senior team | --- | --- | --- | --- | |-------|-------|-------|--------------------------------------------| | | | | LEFT TO RIGHT | | | | | Fiona Sharp | | | | | Group Controller | | | | | Sam Barker | | | | | Director Business Development | | | | | Stephen Stamp | | | | | CEO and CFO | | | | | Paul Seaman | | | | | VP Pharmaceutical & Technology Development | | | | | Steve Damment | | | | | EVP R&D | 2 Disclaimer The following presentation, including a hard cop ...

Midatech Pharma plc (MTP) Q2 2020 Earnings Conference Call September 10, 2020 9:00 AM ET Company Participants Tim Sparey - Chief Business Officer Stephen Stamp - CEO & CFO Conference Call Participants Tim Sparey Good afternoon from Cardiff and welcome to the Midatech Pharma 2020 Interim Results Presentation. With me is Stephen Stamp; CEO and CFO of the company who will run through the presentation. At the end of the presentation there will be a question-and-answer session. We've already received some questi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ OR o SHELL COMPANY PURSUANT T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _______________ OR ☐ SHELL COMPANY PURSUANT T ...